Using cardiovascular magnetic resonance to define mechanisms of comorbidity and to measure the effect of biological therapy: the CADERA observational study
- 1 March 2021
- journal article
- Published by National Institute for Health and Care Research in Efficacy and Mechanism Evaluation
- Vol. 8 (4), 1-42
- https://doi.org/10.3310/eme08040
Abstract
Efficacy and Mechanism Evaluation Volume: 8, Issue: 4, Published in March 2021Keywords
Funding Information
- Efficacy and Mechanism Evaluation Programme (11/117/27)
- Medical Research Council
- Pfizer Ltd
This publication has 31 references indexed in Scilit:
- Cardiovascular effects of biological versus conventional synthetic disease-modifying antirheumatic drug therapy in treatment-naïve, early rheumatoid arthritisAnnals Of The Rheumatic Diseases, 2020
- EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 updateAnnals Of The Rheumatic Diseases, 2016
- Systemic inflammation and cardiovascular risk factors predict rapid progression of atherosclerosis in rheumatoid arthritisAnnals Of The Rheumatic Diseases, 2014
- Cardiovascular comorbidities antedating the diagnosis of rheumatoid arthritisAnnals Of The Rheumatic Diseases, 2012
- How early in the course of rheumatoid arthritis does the excess cardiovascular risk appear?Annals Of The Rheumatic Diseases, 2012
- Does rheumatoid arthritis equal diabetes mellitus as an independent risk factor for cardiovascular disease? A prospective studyArthritis Care & Research, 2009
- EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritisAnnals Of The Rheumatic Diseases, 2009
- Rheumatoid arthritis versus diabetes as a risk factor for cardiovascular disease: a cross-sectional study, the CARRÉ InvestigationAnnals Of The Rheumatic Diseases, 2008
- Cardiovascular death in rheumatoid arthritis: A population‐based studyArthritis & Rheumatism, 2005
- High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factorsArthritis & Rheumatism, 2001